Want to join the conversation?
Foster City, California-based drug maker $GILD said that the U.S. Food and Drug Administration has approved Odefsey for the treatment of HIV-1 infection. Odefsey is $GILD's second TAF-based regimen to receive FDA approval, and represents the smallest pill of any single tablet regimen for the treatment of HIV.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!